Literature DB >> 10425605

Analysis of Fas-ligand interactions using a molecular model of the receptor-ligand interface.

J Bajorath1.   

Abstract

A molecular model of the complex between Fas and its ligand was generated to better understand the location and putative effects of site-specific mutations, analyze interactions at the Fas-FasL interface, and identify contact residues. The modeling study was conservative in the sense that regions in Fas and its ligand which could not be predicted with confidence were omitted from the model to ensure accuracy of the analysis. Using the model, it was possible to map four of five N-linked glycosylation sites in Fas and FasL and to study 10 of 11 residues previously identified by mutagenesis as important for binding. Interactions involving six of these residues could be analyzed in detail and their importance for binding was rationalized based on the model. The predicted structure of the Fas-FasL interface was consistent with the experimentally established importance of these residues for binding. In addition, five previously not targeted residues were identified and predicted to contribute to binding via electrostatic interactions. Despite its limitations, the study provided a much improved basis to understand the role of Fas and FasL residues for binding compared to previous residue mapping studies using only a molecular model of Fas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425605     DOI: 10.1023/a:1008031200961

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  29 in total

1.  Characterization of Fas (Apo-1, CD95)-Fas ligand interaction.

Authors:  P Schneider; J L Bodmer; N Holler; C Mattmann; P Scuderi; A Terskikh; M C Peitsch; J Tschopp
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  Prediction of the three-dimensional structure of the human Fas receptor by comparative molecular modeling.

Authors:  J Bajorath; A Aruffo
Journal:  J Comput Aided Mol Des       Date:  1997-01       Impact factor: 3.686

3.  Exhaustive matching of the entire protein sequence database.

Authors:  G H Gonnet; M A Cohen; S A Benner
Journal:  Science       Date:  1992-06-05       Impact factor: 47.728

4.  Detailed comparison of two molecular models of the human CD40 ligand with an x-ray structure and critical assessment of model-based mutagenesis and residue mapping studies.

Authors:  J Bajorath
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

5.  The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1998.

Authors:  A Bairoch; R Apweiler
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

Review 6.  Modularity in the TNF-receptor family.

Authors:  J H Naismith; S R Sprang
Journal:  Trends Biochem Sci       Date:  1998-02       Impact factor: 13.807

7.  Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes.

Authors:  J W Ponder; F M Richards
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

8.  The role of polar interactions in the molecular recognition of CD40L with its receptor CD40.

Authors:  J Singh; E Garber; H Van Vlijmen; M Karpusas; Y M Hsu; Z Zheng; J H Naismith; D Thomas
Journal:  Protein Sci       Date:  1998-05       Impact factor: 6.725

9.  Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40.

Authors:  G C Starling; P A Kiener; A Aruffo; J Bajorath
Journal:  Biochemistry       Date:  1998-03-17       Impact factor: 3.162

10.  The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution.

Authors:  M J Eck; M Ultsch; E Rinderknecht; A M de Vos; S R Sprang
Journal:  J Biol Chem       Date:  1992-02-05       Impact factor: 5.157

View more
  4 in total

1.  Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism.

Authors:  Akihiro Hasegawa; Xin Cheng; Kiichi Kajino; Alan Berezov; Kaoru Murata; Toshinori Nakayama; Hideo Yagita; Ramachandran Murali; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

2.  Overexpression of cyclooxygenase-2 in malignant peripheral nerve sheath tumor and selective cyclooxygenase-2 inhibitor-induced apoptosis by activating caspases in human malignant peripheral nerve sheath tumor cells.

Authors:  Michiyuki Hakozaki; Takahiro Tajino; Shinichi Konno; Shinichi Kikuchi; Hitoshi Yamada; Michiro Yanagisawa; Jun Nishida; Hiroyuki Nagasawa; Takashi Tsuchiya; Akira Ogose; Masafumi Abe; Hiroshi Hojo
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

3.  Preparation of a functional fluorescent human Fas ligand extracellular domain derivative using a three-dimensional structure guided site-specific fluorochrome conjugation.

Authors:  Michiro Muraki
Journal:  Springerplus       Date:  2016-07-07

4.  Posttranslational regulation of Fas ligand function.

Authors:  Matthias Voss; Marcus Lettau; Maren Paulsen; Ottmar Janssen
Journal:  Cell Commun Signal       Date:  2008-12-29       Impact factor: 5.712

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.